Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
Countries: Germany Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 21 results found since Jan 2013.
Evaluating public interest in herpes zoster in Germany by leveraging the internet: a retrospective search data analysis
CONCLUSIONS: The study demonstrated that evaluating internet search data is a viable method for assessing public interest in HZ, thereby identifying areas of unmet need to support targeted public health campaigns.PMID:37580664 | DOI:10.1186/s12889-023-16463-4
Source: Herpes - August 14, 2023 Category: Infectious Diseases Authors: Alphina Kain Linda Tizek Hannah Wecker Fabian Walln öfer Tilo Biedermann Alexander Zink Source Type: research
Herpes Zoster Virus Reactivation in a 16 Year Old Female Post COVID-19 Vaccine. Case report and Review of the Literature
CONCLUSION: Varicella zoster virus falls under the family of Herpesviridae, It's characterized by its ability to escape host immune system and remain dormant in ganglionic neurons. Reactivation of the infection will result in herpes zoster manifesting as painful vesicles in a dermatomal distribution. Possible link is the suppression of type-one interferons caused by the mRNA-based vaccine such as COVID-19 vaccines. Yet, potential correlation remains to be demonstrated.PMID:37260797 | PMC:PMC10227837 | DOI:10.5455/medarh.2023.77.146-149
Source: Herpes - June 1, 2023 Category: Infectious Diseases Authors: Sadan Alharbi Mohammed Alsubaie Remah Alzayyat Batool Alattas Hassan AlAhmadi Hanoof Alabdullatif Source Type: research
Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases
CONCLUSIONS: The frequencies of vaccinations against influenza, Streptococcus pneumoniae and HZ have increased during recent years. While this can be partly explained by continuous efforts in patient education during the outpatient visits, the COVID-19 pandemic might also have contributed. Nevertheless, the persistently high incidence and mortality of these preventable diseases in patients with AIIRDs mandates further efforts to increase vaccination coverage, particularly in SLE patients.PMID:37112672 | PMC:PMC10146832 | DOI:10.3390/vaccines11040760
Source: Herpes - April 28, 2023 Category: Infectious Diseases Authors: Marco Krasselt Ulf Wagner Olga Seifert Source Type: research
Epidemiology of Clostridioides difficile Infections in Germany, 2010-2019: A Review from Four Public Databases
CONCLUSIONS: All four public sources documented a decline in CDI cases since 2013, but the disease burden remains substantial and warrants continued attention as a severe public health challenge.PMID:36897556 | DOI:10.1007/s40121-023-00785-2
Source: Herpes - March 10, 2023 Category: Infectious Diseases Authors: Gordon Brestrich Frederick J Angulo Fabian K Berger Christian Br ösamle Stefan Hagel Andreas Leischker Christoph L übbert Friederike Maechler Sophie-Susann Merbecks Nadia Minarovic Jennifer C Mo ïsi Lutz von M üller Phillip A Reuken Thomas Weinke Holl Source Type: research
Cutaneous reactions following COVID-19 vaccination assessed by dermatologists: a single-institutional study in Germany
CONCLUSIONS: It can be assumed that vaccination may trigger immune activation-related reactions especially in those patients predisposed to develop respective skin diseases.PMID:36892192 | DOI:10.1111/ddg.14987
Source: Herpes - March 9, 2023 Category: Infectious Diseases Authors: Rosi Wang Sonja Mathes Carla Claussen Tilo Biedermann Knut Brockow Source Type: research
Controlled non-randomised before-after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients-The Easy Vaccination in Oncology (EVO) strategy
CONCLUSION: This easy-to-implement and resource-saving approach has the potential to increase vaccination rates in oncological patients and to have a considerable impact protecting oncological patients from preventable infectious diseases.CLINICAL TRIAL REGISTRATION: The study was registered at the German Resister for Clinical Studies (DRKS) under DRKS00020118.PMID:36221170 | DOI:10.1111/ecc.13725
Source: Herpes - October 12, 2022 Category: Infectious Diseases Authors: Til R Kiderlen Katrin Trostdorf Nicola Delmastro Arne Salomon Christian W Scholz Ernst Sp äth-Schwalbe Veit Mansmann Stephanie Roll Mark Reinwald Maike de Wit Source Type: research
Optimizing Immunization Strategies in Adult Patients With Chronic Liver Disease and Liver Transplant Recipients
This article summarizes recommendations from the Advisory Committee on Immunization Practices for vaccinations in patients with CLD and liver transplant recipients, and includes a discussion of the influenza, herpes zoster, hepatitis A, hepatitis B, pneumococcal, human papillomavirus, and COVID-19 vaccines.PMID:35505940 | PMC:PMC9053492
Source: Herpes - May 4, 2022 Category: Infectious Diseases Authors: Stacey Rolak Adnan Said Rita German Mary S Hayney Freddy Caldera Source Type: research
Herpes zoster-prevention, diagnosis, and treatment
CONCLUSION: Implementation of the current recommendations for the prevention, diagnosis and treatment of HZ and PHN is important to reduce the high burden of disease and improve quality of life of the patients.PMID:35477786 | DOI:10.1007/s00105-022-04992-9
Source: Herpes - April 28, 2022 Category: Infectious Diseases Authors: Ricardo Niklas Werner Kamran Ghoreschi Source Type: research
A clinically validated, broadly active, oral viral superinfection therapy could mitigate symptoms in early-stage COVID-19 patients
Infect Disord Drug Targets. 2022 Apr 19. doi: 10.2174/1871526522666220419130403. Online ahead of print.ABSTRACTMore than 200 viruses infect humans but drugs are available for fewer than ten. To narrow the gap between 'bugs and drugs', a paradigm shift is required. The "one drug, one bug" approach should be supplemented by the "one drug, multiple bugs" strategy such that the host is targeted rather than the virus. The revolutionary viral superinfection therapy (SIT) activates the antiviral interferon gene natural defense system of host cells from within by an attenuated infectious bursal disease virus (IBDV) that releases i...
Source: Infectious Disorders Drug Targets - April 20, 2022 Category: Infectious Diseases Authors: Tibor Bakacs Volker Sandig Shimon Slavin Serhat Gumrukcu W David Hardy Wolfgang Renz Imre Kovesdi Source Type: research
